Recombinant Human bsd Protein，His

The study of BSD (Bacillus subtilis d-amino acid oxidase) recombinant proteins has garnered significant interest due to their potential applications in biotechnology and medicine. BSD, an enzyme originally derived from the bacterium Bacillus subtilis, is known for its ability to catalyze the oxidation of d-amino acids, which are not commonly found in nature and are important for various biological processes. The recombinant production of BSD proteins allows for the exploration of their functional properties, enzyme kinetics, and interactions with substrates and inhibitors. Researchers aim to optimize expression systems and purification methods, enhancing yield and stability for industrial applications. Additionally, understanding BSD's structural features through techniques like X-ray crystallography or NMR can facilitate the design of engineered variants with improved enzymatic activity or selectivity. Importantly, BSD proteins may serve therapeutic roles, particularly in developing novel treatments for bacterial infections or conditions associated with d-amino acids. As a result, the recombinant expression and characterization of BSD proteins present valuable opportunities for advancing both fundamental enzyme research and its practical implications in health and industry.